A Modified Classification of Prognostic Factors Based on Pathological Stage and Tumor Regression Grade in Patients with Rectal Cancer Who Receive Preoperative Chemoradiotherapy [0.03%]
基于术前放化疗患者病理分期和肿瘤消退分级的预后因素分类的改良分型
Toshiyuki Suzuki,Sotaro Sadahiro,Akira Tanaka et al.
Toshiyuki Suzuki et al.
Objective: The histologic response to neoadjuvant chemoradiotherapy (CRT) has been intimately related to outcomes in locally advanced rectal cancer. However, reliable prognostic factors have yet to be established. ...
Effect of Neoadjuvant Nab-Paclitaxel plus Gemcitabine Therapy on Overall Survival in Patients with Borderline Resectable Pancreatic Cancer: A Prospective Multicenter Phase II Trial (NAC-GA Trial) [0.03%]
纳米白蛋白结合型紫杉醇联合吉西他滨新辅助治疗边缘可切除胰腺癌的总生存期：前瞻性多中心Ⅱ期临床试验（NAC-GA试验）
Ken-Ichi Okada,Toshio Shimokawa,Seiko Hirono et al.
Ken-Ichi Okada et al.
We conducted a prospective multicenter phase II trial of patients with borderline resectable pancreatic carcinoma to investigate the efficacy of neoadjuvant nab-paclitaxel plus gemcitabine therapy on overall survival (OS). The clinical tria...
Clinical Trial
Oncology. 2017;93(5):343-346. DOI:10.1159/000478660 2017
Hiroaki Nozawa,Soichiro Ishihara,Kazushige Kawai et al.
Hiroaki Nozawa et al.
Objective: Difficulties are associated with the management of brain metastasis (BM), which portends a poor prognosis in the treatment of colorectal cancer (CRC). The aim of the present study was to identify risk factors f...
Tobias R Overbeck,Johanna Arnemann,Regina Waldmann-Beushausen et al.
Tobias R Overbeck et al.
Background: ATP-binding cassette transport protein A3 (ABCA3) is expressed in non-small cell lung cancer (NSCLC). We hypothesize that high-level ABCA3 expression may have a negative prognostic impact in patients with NSCL...
Natural History of T1N0M0 Hepatocellular Carcinoma: Large-Scale Study in the United States [0.03%]
美国大规模T1N0M0期肝细胞癌的自然史研究
Humaid O Al-Shamsi,Reham Abdel-Wahab,Manal M Hassan et al.
Humaid O Al-Shamsi et al.
Background: Hepatocellular carcinoma (HCC) prognosis depends on clinicopathological features in addition to the treatment provided. We aimed to assess the natural history of TNM stage I HCC tumors which received different...
101 Long-Term Survivors Who Had Metastatic Gastroesophageal Cancer and Received Local Consolidative Therapy [0.03%]
101例接受局部巩固治疗的转移性胃食管癌长期生存者
Dilsa Mizrak Kaya,Xuemei Wang,Kazuto Harada et al.
Dilsa Mizrak Kaya et al.
Background: Through a multidisciplinary decision-making process, we developed a strategy of systemic therapy followed by local consolidative therapy (chemoradiation with/without surgery) in selected patients with metastat...
Integrative Assessment of Pretreatment Inflammation-, Nutrition-, and Muscle-Based Prognostic Markers in Patients with Muscle-Invasive Bladder Cancer Undergoing Radical Cystectomy [0.03%]
肌侵袭性膀胱癌根治术后炎症、营养及肌肉预后标志物的综合评估
Makito Miyake,Yosuke Morizawa,Shunta Hori et al.
Makito Miyake et al.
Objective: The present study evaluated the clinical relevance of an integrative preoperative assessment of inflammation-, nutrition-, and muscle-based markers for patients with muscle-invasive bladder cancer (MIBC) underg...
Comparative Study
Oncology. 2017;93(4):259-269. DOI:10.1159/000477405 2017
Complementary and Alternative Medicine: A Clinical Study in 1,016 Hematology/Oncology Patients [0.03%]
1016例血液肿瘤患者补充和替代医学治疗的临床研究
Marina Hierl,Jochen Pfirstinger,Reinhard Andreesen et al.
Marina Hierl et al.
Introduction: Surveys state a widespread use of complementary and alternative medicine (CAM) in patients with malignant diseases. CAM methods might potentially interfere with the metabolization of tumor-specific therapy. ...
Tumor-Associated Macrophages in the Development of 4-Nitroquinoline-1-Oxide-Induced Tongue Squamous Cell Carcinoma in a Mouse Model [0.03%]
4-硝基喹啉-1-氧化物致小鼠舌鳞状细胞癌的肿瘤相关巨噬细胞研究
Kentaro Miki,Yorihisa Orita,Yuka Gion et al.
Kentaro Miki et al.
Objective: We aimed to determine the distribution of tumor-associated macrophages (TAMs) in the development of tongue squamous cell carcinoma (SCC) and to elucidate the role of TAMs in the progression of tongue SCC. ...
Optimizing Quality of Life in Patients with Hormone Receptor-Positive Metastatic Breast Cancer: Treatment Options and Considerations [0.03%]
激素受体阳性转移性乳腺癌患者的生活质量优化：治疗选择和考虑因素
Pavani Chalasani
Pavani Chalasani
The treatment landscape for hormone receptor-positive metastatic breast cancer continues to evolve as the molecular mechanisms of this heterogeneous disease are better understood and targeted treatment strategies are developed. Patients are...